BIOMARKER:

EGFR S768I

Entrez ID:

Related biomarkers:

‹

›

EGFR S768I EGFR S768I	Non Small Cell Lung Cancer NSCLC	afatinib Sensitive: B - Late Trials
EGFR S768I EGFR S768I	Lung Adenocarcinoma LUAD	erlotinib Sensitive: C2 – Inclusion Criteria
EGFR S768I EGFR S768I	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C2 – Inclusion Criteria
EGFR S768I EGFR S768I	Non Small Cell Lung Cancer NSCLC	osimertinib Sensitive: C2 – Inclusion Criteria
EGFR S768I EGFR S768I	Non Small Cell Lung Cancer NSCLC	gefitinib Resistant: C3 – Early Trials
EGFR S768I EGFR S768I	Lung Adenocarcinoma LUAD	afatinib Resistant: C3 – Early Trials
EGFR S768I EGFR S768I	Non Small Cell Lung Cancer NSCLC	Tyrosine kinase inhibitor Sensitive: C3 – Early Trials

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations